REQUEST A DEMO
Total
USD $0.00
Search more companies

Fidson Healthcare Plc (Nigeria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Fidson Healthcare Plc Profile Updated: July 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Fidson Healthcare is a company that manufactures antipyretic and analgesic products, such as Paracetamol Syrup, for the resolution of fever and pains in children.

Headquarters
268, Ikorodu Road, Obanikoro
Lagos; Lagos; Postal Code: 100232

Contact Details: Purchase the Fidson Healthcare Plc report to view the information.

Website: http://www.fidson.com

Basic Information
Total Employees:
Purchase the Fidson Healthcare Plc report to view the information.
Outstanding Shares:
Purchase the Fidson Healthcare Plc report to view the information.
Financial Auditors:
Purchase the Fidson Healthcare Plc report to view the information.
Incorporation Date:
1995
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
33.05%
Purchase this report to view the information.
24.67%
Subsidiaries
Fil Pahrmaceuticals Limited
100%
Widenet Impex Limited
100%
Company Performance
Financial values in the chart are available after Fidson Healthcare Plc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency NGN. Absolute financial data is included in the purchased report.
Net sales revenue
45.63%
Total operating revenue
45.55%
Operating profit (EBIT)
49.95%
EBITDA
47.71%
Net Profit (Loss) for the Period
-45.43%
Total assets
58.46%
Total equity
5.65%
Operating Profit Margin (ROS)
0.69%
Net Profit Margin
-6.78%
Return on Equity (ROE)
-6.8%
Debt to Equity Ratio
89.68%
Quick Ratio
-0.22%
Cash Ratio
-0.05%

Similar companies

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?